Tonix Pharmaceuticals 8-K Report: Key Updates for December 2024
Based on the provided section of the financial report, here are the key points extracted:
- Entity Information:
- Company Name: Tonix Pharmaceuticals Holding Corp.
- CIK Number: 0001430306
- SEC File Number: 001-36019
- Tax ID: 26-1434750
- Address: 26 Main Street, Chatham, NJ 07928
- Contact Number: (862) 904-8182
- Filing Type:
- Filing Type: 8-K (current report)
- Filing Date:
- Filing Date: December 23, 2024
- Stock Information:
- Common Stock Ticker: TNXP
- Exchange: NASDAQ
- Reporting Period:
- Period Start Date: December 23, 2024
- Period End Date: December 23, 2024
- Units of Measure:
- Monetary Unit: USD (United States Dollar)
- Shares Unit: Shares (for stock measurement)
- USD per Share Measurement: USD/Shares
Insights:
- The filing indicates a significant update or event for Tonix Pharmaceuticals, as 8-K forms are typically used to report major company events that shareholders should know about.
- The report is recent, dated December 23, 2024, suggesting that the information is highly relevant and up-to-date.
- The fact that the company is listed on NASDAQ suggests it is a publicly traded entity, which may provide further investment opportunities or risks depending on the context of the filing.
- The inclusion of the specific address and contact information can facilitate further inquiries or due diligence by investors or analysts.
This information can serve as a foundation for deeper analysis into the company's performance, recent developments, and overall market position.